ArticleCell reports. Medicine2025

Spatial and genomic profiling of residual breast cancer after neoadjuvant chemotherapy unveil divergent fates for each breast cancer subtype.

Eun Seop Seo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.